Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
‘I felt like a criminal asking for naloxone’
Kimberley, who lives with chronic pain, asked for naloxone along with her opioid prescription. The pharmacist’s response shocked her.
NSW announces major change to vaccine and medicines access
Three big healthcare wins were announced by NSW Premier Dominic Perrottet earlier this week to improve access to medicines and vaccines.
Q&A: Terry White co-founder Rhonda White
Australian Pharmacist spoke to Rhonda White AO about her role in co-founding Terry White Chemists (TWC) – the first group to franchise pharmacies in...
Why are so many adults diagnosed with ADHD these days?
An expert weighs in on the legitimacy of ADHD diagnoses and where pharmacists fit into the equation.
Bringing pharmacy skills to the MasterChef kitchen
Years of calculating exact medication dosages mirror Depinder Chhibber’s meticulous approach in the MasterChef Australia kitchen.
Treatment of acute pain with Pharmacist Only (S3) celecoxib
Effectively managing acute pain is a crucial aspect of patient care. This article explores current Pharmacist Only options for pain management following the recent market entry of Pharmacist Only celecoxib.
